BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20473733)

  • 61. Prospective randomized comparison of chemoembolization with doxorubicin-eluting beads and bland embolization with BeadBlock for hepatocellular carcinoma.
    Malagari K; Pomoni M; Kelekis A; Pomoni A; Dourakis S; Spyridopoulos T; Moschouris H; Emmanouil E; Rizos S; Kelekis D
    Cardiovasc Intervent Radiol; 2010 Jun; 33(3):541-51. PubMed ID: 19937027
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evaluation by survival analysis on effect of traditional Chinese medicine in treating children with respiratory syncytial viral pneumonia of phlegm-heat blocking Fei syndrome.
    Yang Y; Wang SC; Bai WJ; Li RL; Ai J
    Chin J Integr Med; 2009 Apr; 15(2):95-100. PubMed ID: 19407945
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical efficacy of transcatheter arterial chemoembolization combined with surgery in the treatment of hepatocellular carcinoma.
    Feng L; Jin-Hua Z; Yong-Yi Z; Jing-Feng L
    Indian J Cancer; 2015 Dec; 52 Suppl 2():e99-101. PubMed ID: 26728684
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Transcatheter arterial chemoembolization alone or combined with ablation for recurrent intermediate-stage hepatocellular carcinoma: a propensity score matching study.
    Wang C; Liao Y; Qiu J; Yuan Y; Zhang Y; Li K; Zou R; Wang Y; Zuo D; He W; Zheng Y; Li B; Yuan Y
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2669-2680. PubMed ID: 32449005
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Assessment of the clinical effect of Chinese medicine therapy combined with psychological intervention for treatment of patients of peri-menopausal syndrome complicated with hyperlipidemia.
    Qian LQ; Wang B; Niu JY; Gao S; Zhao DY
    Chin J Integr Med; 2010 Apr; 16(2):124-30. PubMed ID: 20473737
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Combined therapy of transcatheter arterial chemoembolisation and three-dimensional conformal radiotherapy for hepatocellular carcinoma.
    Zhou ZH; Liu LM; Chen WW; Men ZQ; Lin JH; Chen Z; Zhang XJ; Jiang GL
    Br J Radiol; 2007 Mar; 80(951):194-201. PubMed ID: 17038412
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical effect of polyvinyl alcohol particles combined with chemoembolization in treatment of hepatocellular carcinoma complicated by hepatic arteriovenous shunt and related and prognostic factors].
    Liu QS; Mei QL; Li YH; He XF; Zeng QL; Pang HJ; Xiao LJ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):834-839. PubMed ID: 27978929
    [No Abstract]   [Full Text] [Related]  

  • 68. [Clinical study of combined Chinese herbal medicine with move stripe field radiation in treating primary hepatocellular carcinoma].
    Han JQ; Chen SD; Zhai LM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1997 Aug; 17(8):465-6. PubMed ID: 10322831
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization.
    Chung JW; Park JH; Han JK; Choi BI; Han MC
    AJR Am J Roentgenol; 1995 Aug; 165(2):315-21. PubMed ID: 7618547
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The long term efficacy of combined transcatheter arterial embolization and percutaneous ethanol injection in the treatment of patients with large hepatocellular carcinoma and cirrhosis.
    Tanaka K; Nakamura S; Numata K; Kondo M; Morita K; Kitamura T; Saito S; Kiba T; Okazaki H; Sekihara H
    Cancer; 1998 Jan; 82(1):78-85. PubMed ID: 9428482
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
    Ando Y; Kawaoka T; Amioka K; Naruto K; Ogawa Y; Yoshikawa Y; Kikukawa C; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Fukuhara T; Mori N; Takaki S; Tsuji K; Nonaka M; Hyogo H; Aisaka Y; Masaki K; Honda Y; Moriya T; Naeshiro N; Takahashi S; Imamura M; Chayama K; Aikata H
    Oncology; 2021; 99(8):507-517. PubMed ID: 33946070
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Transarterial Radioembolization Versus Concurrent Chemoradiation Therapy for Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Song JE; Jung KS; Kim DY; Song K; Won JY; Lee HW; Kim BK; Kim SU; Park JY; Ahn SH; Seong J; Han KH
    Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):396-406. PubMed ID: 28871990
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis.
    Takayasu K; Arii S; Ikai I; Kudo M; Matsuyama Y; Kojiro M; Makuuchi M;
    AJR Am J Roentgenol; 2010 Mar; 194(3):830-7. PubMed ID: 20173167
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The palliative treatment of primary hepatocellular carcinoma by chemoembolization].
    Hasan I; Wickenhöfer R; Görich J; Hartlapp JH; Reiser M
    Dtsch Med Wochenschr; 1992 Apr; 117(15):576-80. PubMed ID: 1373113
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Percutaneous alcohol instillation therapy (PAI) and chemoembolization in extensive hepatocellular carcinoma].
    Adamus R; Tesdal IK; Georgi M
    Rofo; 1997 Feb; 166(2):173-5. PubMed ID: 9116264
    [No Abstract]   [Full Text] [Related]  

  • 77. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.
    Yoon SM; Lim YS; Won HJ; Kim JH; Kim KM; Lee HC; Chung YH; Lee YS; Lee SG; Park JH; Suh DJ
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2004-11. PubMed ID: 21621346
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Comparative study of several microinvasive treatments for large hepatocellular carcinoma.
    Tu JF; Xu HH; Ying XH; Wang YH; Zhang DK; Tu CY; Ji JS
    Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):45-53. PubMed ID: 25635974
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adjuvant celecoxib and lanreotide following transarterial chemoembolisation for unresectable hepatocellular carcinoma: a randomized pilot study.
    Tong H; Wei B; Chen S; Xie YM; Zhang MG; Zhang LH; Huang ZY; Tang CW
    Oncotarget; 2017 Jul; 8(29):48303-48312. PubMed ID: 28430638
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Chinese material medica combined with cisplatin and lipiodol through transcatheter arterial embolization in the treatment of primary hepatoma].
    Yu ZJ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jun; 13(6):327-9, 323. PubMed ID: 8257833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.